Literature DB >> 22994396

Population impact of reimbursement for smoking cessation: a natural experiment in The Netherlands.

Marc C Willemsen1, Dewi Segaar, Onno C P van Schayck.   

Abstract

AIMS: To report on the impact of financial reimbursement of pharmacotherapy for smoking cessation in combination with behavioural support on the number of enrollees to proactive counselling in the Dutch national quitline.
DESIGN: Descriptive time-series analysis was used to compare quitline enrolment in 2010 and 2012 (no reimbursement) with 2011 (reimbursement). SETTINGS: National smoking cessation quitline. PARTICIPANTS: Smokers signing up for proactive counselling. MEASUREMENTS: Treatment enrolment data recorded by the quitline as part of usual care from 2010, 2011 and 2012 (until May).
FINDINGS: In 2010, a total of 848 smokers started treatment. In 2011, 9091 smokers enrolled. In 2012, the number of enrollees dropped dramatically, even below the 2010 level. In addition, the proportion of smokers in the population dropped from 27.2% in 2010 to 24.7% in 2011.
CONCLUSIONS: The introduction of a national reimbursement system in the Netherlands was associated with a more than 10-fold increase in telephone counselling for smoking cessation and suggests that reimbursement for smoking cessation contributed to improvements in public health.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2012        PMID: 22994396     DOI: 10.1111/j.1360-0443.2012.04089.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  Commentary on Willemsen et al. (2013): Increasing demand for smoking cessation on a national level.

Authors:  Sheila Alessi; David M Ledgerwood
Journal:  Addiction       Date:  2013-03       Impact factor: 6.526

2.  Are there income differences in the impact of a national reimbursement policy for smoking cessation treatment and accompanying media attention? Findings from the International Tobacco Control (ITC) Netherlands Survey.

Authors:  Gera E Nagelhout; Karin Hummel; Marc C Willemsen; Mohammad Siahpush; Anton E Kunst; Hein de Vries; Geoffrey T Fong; Bas van den Putte
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

Review 3.  Healthcare financing systems for increasing the use of tobacco dependence treatment.

Authors:  Floor A van den Brand; Gera E Nagelhout; Ayalu A Reda; Bjorn Winkens; Silvia M A A Evers; Daniel Kotz; Onno Cp van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

4.  Barriers to the provision of smoking cessation assistance: a qualitative study among Romanian family physicians.

Authors:  Catalina Panaitescu; Mandy A Moffat; Siân Williams; Hilary Pinnock; Melinda Boros; Cristian Sever Oana; Sandra Alexiu; Ioanna Tsiligianni
Journal:  NPJ Prim Care Respir Med       Date:  2014-07-10       Impact factor: 2.871

5.  Subsidized pharmacological treatment for smoking cessation by the Spanish public health system: A randomized, pragmatic, clinical trial by clusters.

Authors:  César Minué-Lorenzo; Eduardo Olano-Espinosa; Isabel Del Cura-González; Jose M Vizcaíno-Sánchez; Francisco Camarelles-Guillem; José A Granados-Garrido; Margarita Ruiz-Pacheco; M Isabel Gámez-Cabero; F Javier Martínez-Suberviola; Encarnación Serrano-Serrano
Journal:  Tob Induc Dis       Date:  2019-09-05       Impact factor: 2.600

6.  How does reimbursement status affect smoking cessation interventions? A real-life experience from the Eastern Black Sea region of Turkey.

Authors:  Dilek Karadoğan; Özgür Önal; Yalçın Kanbay
Journal:  Tob Induc Dis       Date:  2019-01-22       Impact factor: 2.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.